Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2007
12/20/2007US20070293555 4-methoxy-benzoic acid 1-imidazol-1-yl methyl-2-(4-fluorophenoxy)-ethyl ester; N-[(1-imidazol-1-yl methyl)-2-phenoxy-ethyl]-4-iodo-benzamide; cancer, inflammation, septic shock, infertility, preterm labor, pain, or an ischemia
12/20/2007US20070293544 Novel 4-Arylamino Pyridone Derivatives as Mek Inhibitors for the Treatment of Hyper-Proliferative Disorders
12/20/2007US20070293540 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition
12/20/2007US20070293528 non-steroidal partial activators and/or tissue-specific activators or inhibtors for androgen receptors, used for treating acne, alopecia, hirsutism, prostatic hyperplasia or prostate cancer
12/20/2007US20070293519 Analogs of thalidomide as potential angiogenesis inhibitors
12/20/2007US20070293517 Derivatives Of Chemotherapeutic Agents With A Formaldehyde Releasing Moiety
12/20/2007US20070293516 Kinase antagonists
12/20/2007US20070293513 Cristalline and amorphous form of a triazolo (4,5-d) pyridimine compound
12/20/2007US20070293504 N-phenyl-2-pyrimidine-amine derivatives
12/20/2007US20070293501 Thioalkeneamides as Transketolase Inhibitors
12/20/2007US20070293496 Nitrogen containing heterocyclic compounds and medicines containing the same
12/20/2007US20070293491 Indazole compounds and methods for inhibition of cdc7
12/20/2007US20070293490 Quinazoline Derivatives
12/20/2007US20070293488 tyrosine kinase inhibitors such as 1-(2-fluoro-5-trifluoromethylphenyl)-3-[4-(5-oxo-5,8-dihydropyrido[2,3-d]pyrimidin-4-ylamino)phenyl]urea, used as antitumor or anticarcinogenic agents or for the treatment of psoriasis, arthritis, retinopathy or dermatitis
12/20/2007US20070293487 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors
12/20/2007US20070293484 Thiophene Heteroaryl Amines
12/20/2007US20070293468 Reacting indazolium hydrochloride with Sodium tetrachlorobisindazoleruthenate(III) to form trans-Indazolium [tetrachlorobisindazoleruthenate(III)] (KP1019), and sodium chloride; both highly effective and water soluble; bioavailability; cancer treatment
12/20/2007US20070293467 Demethyl-Cantharidin Platinum Complex Isomers and Their Use
12/20/2007US20070293453 Combinatorial Methods For Inducing Cancer Cell Death
12/20/2007US20070293424 Antitumoral and Antiviral Peptides
12/20/2007US20070293418 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive and nervous system disorders
12/20/2007US20070292885 Human cdnas and proteins and uses thereof
12/20/2007US20070292528 Kcnma1 as a Therapeutic Target in Cancer Treatment
12/20/2007US20070292513 Pazopanib hydrochloride and synthesis, chemical intermediates, and dosage forms thereof; anticancer; colon cancer, breast cancer
12/20/2007US20070292497 Method for treating micrometastatic tumors
12/20/2007US20070292461 Oleaginous pharmaceutical and cosmetic foam
12/20/2007US20070292452 Vaccine Compositions Which Are Obtained From Streptomyces
12/20/2007US20070292441 Tumor Specific Antibody
12/20/2007US20070292430 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
12/20/2007US20070292424 Novel human eosinophil-derived basic protein
12/20/2007US20070292422 Using CD70 specific immunoglobulins to prevent and treat cell proliferative disorders; immunosuppressant
12/20/2007US20070292419 Treatment with anti-erbb2 antibodies
12/20/2007US20070292413 Comprised of three lipid elements: phosphatidyl choline, fatty-acyl-cholesterol esters, and at least one apolipoprotein; brain disorders; kits; efficiently target and deliver substances
12/20/2007US20070292405 Uses of Erss Modulators
12/20/2007US20070292394 Treatment of non-neuronal cancer using hsv-1 variants
12/20/2007US20070292389 Method for the Purification and Amplification of Tumoral Stem Cells
12/20/2007US20070292359 Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
12/20/2007US20070292355 Alcohol-free drug or cosmetics carrier mixture of water, hydrophobic solvent, surfactant and gelling agent; oil in water emulsions
12/20/2007US20070292353 Nanoparticles Comprising an Intracellular Targeting Element and Preparation and Use Thereof
12/20/2007US20070292350 Method For Testing A Compound For A Therapeutic Effect And A Diagnostic Method
12/20/2007US20070292346 Lng105 Antibody Composition and Methods of Use, and Use of Lng105 to Assess Lung Cancer Risk
12/20/2007DE20321542U1 Reinstes rac-1-{4-[2-Hydroxy-3-(5-quinolyloxy) propyl]-piperazin-1-ylß-2,2-diphenylethan-1-one-fumarat Purest rac-1- {4- [2-hydroxy-3- (5-quinolyloxy) propyl] -piperazine-1-ylß-2,2-diphenylethan-1-one fumarate
12/20/2007DE19943708B4 Neue C13-substituierte Estra-1,3,5(10)-trien-3-yl-sulfamate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen New C13-substituted estra-1,3,5 (10) -triene-3-yl-sulfamate, to their preparation and to pharmaceutical compositions containing these compounds, method
12/20/2007DE102004018441B4 D-Homo-17-chlor-16(17)en Steroide D-homo-17-chloro-16 (17) en steroids
12/19/2007EP1867721A1 Angiostatin fragments and aggregate angiostatin and methods of use
12/19/2007EP1867718A2 Therapeutically useful synthetic oligonucleotides
12/19/2007EP1867673A1 Coordination compound composed of diaminocyclohexane platinum (ii) and block copolymer and anti-cancer agent comprising the same
12/19/2007EP1867661A1 Compositions and methods for delivering anti-activated ras antibodies into cells
12/19/2007EP1867658A1 Lactalbumin production process
12/19/2007EP1867649A1 Piperidyl-2, 6-dione derivatives used to inhibit cells from releasing tumor necrosis factor
12/19/2007EP1867648A1 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them.
12/19/2007EP1867647A1 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them.
12/19/2007EP1867645A1 Variolin derivatives and their use as antitumor agents
12/19/2007EP1867640A1 Agent for treatment of solid tumor
12/19/2007EP1867633A1 Polyamine analogues as therapeutic and diagnostic agents
12/19/2007EP1867338A1 Pharmaceutical composition comprising apolipoproteins for the treatment of human diseases
12/19/2007EP1867335A2 Formulations with angiogenesis-dependent tumour action
12/19/2007EP1866339A2 Gitr binding molecules and uses therefor
12/19/2007EP1866338A1 Antibodies against cd38 for treatment of multiple myeloma
12/19/2007EP1866332A1 Use of crotamine, kit and composition
12/19/2007EP1866324A1 Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer
12/19/2007EP1866319A1 Phosphono-pent-2-en-1-yl nucleosides and analogs
12/19/2007EP1866311A2 Novel compounds
12/19/2007EP1866306A1 Imidazopyridine derivatives useful as inos inhibitors
12/19/2007EP1866302A1 Pyrazole derivatives
12/19/2007EP1866292A1 Tricyclic 1,2,4-triazine oxides and compositions therefrom for therapeutic use in cancer treatments
12/19/2007EP1866288A1 Indazole squaric acid derivatives as chk1-, chk2- and sgk- inhibitors
12/19/2007EP1865991A2 Cytotoxic compounds and conjugates comprising duocarmycins with cleavable substrates
12/19/2007EP1865986A2 Anti-ctla-4 antibody compositions
12/19/2007EP1865972A2 Treatment or prevention of cancer and precancerous disorders
12/19/2007EP1865964A1 Topical formulations for use in the treatment or prevention of dermatological conditions
12/19/2007EP1865954A2 Methods for avoiding edema in the treatment or prevention of ppar gamma-responsive diseases, including cancer
12/19/2007EP1865951A1 Method for preventing cardiovascular diseases
12/19/2007EP1865950A1 Compounds useful as modulators of the proteasome activity
12/19/2007EP1865949A2 Modulators of atp-binding cassette transporters
12/19/2007EP1865778A2 Methods for avoiding edema in the treatment of metabolic, inflammatory, and cardiovascular disorders
12/19/2007EP1784172A4 Cancer chemotherapy
12/19/2007EP1546152B1 Epothilone derivatives
12/19/2007EP1503757B1 Tyrosine kinase inhibitors
12/19/2007EP1490062B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/19/2007EP1470122B1 Rho-kinase inhibitors
12/19/2007EP1434567B1 Method for preparing a compound for interaction of active substances with a porous support using supercritical fluid
12/19/2007EP1422224B1 Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin
12/19/2007EP1420802B1 Increased solubility flavanolignan preparations
12/19/2007EP1406872B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes
12/19/2007EP1339665B1 Nitroderivatives as drugs for diseases having an inflammatory basis
12/19/2007EP1326856B1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity
12/19/2007EP1303599B1 Methylated nucleotide regulation of upa gene expression
12/19/2007EP1165068B1 C10 heterosubstituted acetate taxanes as antitumor agents
12/19/2007EP1095061B1 Peptides based on the sequence of human lactoferrin and their use
12/19/2007EP1091757B1 Alpha emitting constructs and uses thereof
12/19/2007EP0772689B1 Retroviral vectors having a reduced recombination rate
12/19/2007CN101090913A Antibodies against tenascin-c
12/19/2007CN101090899A 2,5- and 2,6-disubstituted benzazole analogues useful as protein kinase inhibitors
12/19/2007CN101090720A Nanoparticulate compositions of tubulin inhibitor compounds
12/19/2007CN101090715A Dendritic cell infiltrativity activating composition and immune activator
12/19/2007CN101089188A Bacterial peptide-X purification technology
12/19/2007CN101089018A Woodfrog egg protein with anticancer function and its prepn process
12/19/2007CN101089008A Dicyclic analog without ring A and ring B of omithogalum caudatum OSW-1 saponin and its synthesis process and use
12/19/2007CN101089004A New type of phosphonate-nucleotide compound
1 ... 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 ... 2211